By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



3104 NE Minnehaha Street

Vancouver  Washington  98663  U.S.A.
Phone: 503-969-9990 Fax: n/a



Company News
HTG Announces Pricing Of IPO 5/6/2015 8:52:46 AM
HTG Announces Completion Of IVD Development And Supply Agreement With Illumina, Inc. (ILMN) 10/30/2014 9:17:14 AM
HTG Receives U.S. Patent For HTG EdgeSeq Chemistry Coupling Quantitative Nuclease Protection With Next-Generation-Sequencing 6/17/2014 10:43:06 AM
HTG Launches An Automated, Sequencing-Based miRNA Whole Transcriptome Digital Gene Expression Assay For Challenging Sample Types 6/11/2014 9:19:54 AM
HTG Launches Two Multiplexed Gene Expression Assays for Use on Award-Winning HTG Edge System 7/2/2013 10:36:17 AM
HTG Launches New Version of MicroRNA Screening Product 9/13/2011 12:04:48 PM
HTG Announces Availability of Fixed Arrays for Rapid Gene Expression Analysis at American Association for Cancer Research Meeting 4/5/2011 9:23:45 AM
HTG Lands $15.7 Million in Series D Financing 2/24/2011 7:06:58 AM
HTG Announces Appointments of John Wineman as Vice President New Business Development - Western Region and Thomas Vasicek, Ph.D. as Vice President Clinical Programs and Product Innovation 9/1/2010 8:23:36 AM
HTG Signs Collaboration Agreement with John Wayne Cancer Institute 5/3/2010 9:57:19 AM